Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2017Q1 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2016Q4 $ vs. 2016Q4
NEUROCRINE BIOSCIENCES INC 3,366,530 $145,771,000 8.30% +50,007 +$17,422,000
Global Blood Therapeutics, Inc. 3,858,978 $142,203,000 8.10% +730,000 +$96,990,000
AMICUS THERAPEUTICS, INC. 17,296,672 $123,325,000 7.03% No Change +$37,361,000
VERSARTIS SHARES 4,407,317 $94,096,000 5.36% +253,632 +$32,207,000
LA JOLLA PHARMACEUTICAL CO 2,139,274 $63,857,000 3.64% +820,000 +$40,730,000
ALNYLAM PHARMACEUTICALS, INC. 1,103,475 $56,553,000 3.22% +985,000 +$52,117,000
Sarepta Therapeutics, Inc. 1,771,029 $52,422,000 2.99% -998,800 -$23,554,000
Retrophin, Inc. 2,807,525 $51,826,000 2.95% +120,113 +$954,000
NxStage Medical, Inc. 1,818,189 $48,782,000 2.78% -109,800 -$1,751,000
Xencor Inc 1,607,018 $38,440,000 2.19% -178,000 -$8,542,000
Aclaris Therapeutics, Inc. 1,260,847 $37,598,000 2.14% No Change +$3,379,000
Tesaro Inc 241,028 $37,087,000 2.11% -446,965 -$55,434,000
VBI Vaccines Inc/BC 6,565,843 $36,046,000 2.05% No Change +$15,692,000
Radius Health, Inc. 910,872 $35,205,000 2.01% +647,000 +$25,170,000
AVEXIS SHARES 448,501 $34,100,000 1.94% -25,030 +$11,498,000
Evolent Health, Inc. 1,444,500 $32,212,000 1.83% +1,136,700 +$27,657,000
VERTEX PHARMACEUTICALS INC / MA 293,509 $32,095,000 1.83% +208,000 +$25,796,000
REGENXBIO Inc. 1,396,244 $26,947,000 1.54% +113,958 +$3,161,000
LION BIOTECHNOLOGIES SHARES 3,567,553 $26,578,000 1.51% No Change +$1,784,000
CytomX Therapeutics, Inc. 1,530,659 $26,434,000 1.51% +606,896 +$16,282,000
ANAPTYSBIO, INC 881,957 $24,474,000 1.39% New +$24,474,000
ZOGENIX, INC. 2,203,302 $23,906,000 1.36% +1,450,303 +$14,757,000
ARDELYX, INC. 1,886,196 $23,860,000 1.36% +50,000 -$2,213,000
GALAPAGOS NV 271,405 $23,392,000 1.33% -33,126 +$2,761,000
DBV Technologies S.A. 591,765 $20,842,000 1.19% -18,878 -$610,000